Use of Cosmetic Facial Injectables After Facial Aesthetic Surgery.

Aesthetic surgery journal 2022 Vol.42(10) p. 1194-1204

Talwar AA, Shulkin JM, Hitchner M, McAuliffe PB, Desai AA, Broach RB, Percec I

관련 도메인

Abstract

[BACKGROUND] Over the last 2 decades, both invasive and minimally invasive aesthetic procedures have proliferated. Aesthetic surgeons often recommend injectable treatments after cosmetic facial surgery for multiple reasons. However, literature is lacking on how cosmetic surgery affects postoperative facial injectable use.

[OBJECTIVES] The aim of this study was to identify predictors of facial injectable use after cosmetic facial surgery.

[METHODS] All adult patients operated on by a single surgeon between 2013 and 2021 were retrospectively reviewed. Patients who had any of the following cosmetic facial surgeries were included: rhytidectomy, blepharoplasty, rhinoplasty, or genioplasty. Patient demographics, clinical history, intraoperative factors, and use of cosmetic facial injectables (neurotoxin, facial fillers, deoxycholic acid, poly-l-lactic acid) were recorded.

[RESULTS] A total of 227 patients who underwent facial cosmetic surgery were reviewed, of whom 158 were included. Of these, 89 patients had rhytidectomy (56.3%), 112 had blepharoplasty (70.9%), 28 had rhinoplasty (17.7%), and 7 had genioplasty (4.4%). Injectables were administered to 44.3% of patients after their surgery (n = 73), compared with only 17.7% before surgery (n = 28) (P < 0.001). The most common postoperative injectables were neurotoxins (48.5%) and facial fillers (46.0%), followed by deoxycholic acid (2.7%) and poly-l-lactic acid (2.7%). Multivariate regression revealed factors positively correlated with future injectable use were index blepharoplasty or rhinoplasty, and history of preoperative neurotoxin injection (P < 0.05).

[CONCLUSIONS] Cosmetic facial injectables are an important consideration in achieving and maintaining optimal facial aesthetics. Their use, especially neurotoxins and facial fillers, has increased among patients postoperatively. These results highlight the contribution of injectable procedures in the context of multidimensional care for augmenting facial aesthetics.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 rhinoplasty 코성형술 dict 3
시술 blepharoplasty 안검성형술 dict 3
시술 rhytidectomy 안면거상술 dict 2
시술 genioplasty 턱끝성형술 dict 2
재료 poly-l-lactic acid 폴리락트산 dict 2
합병증 facial scispacy 1
약물 deoxycholic acid C0011479
deoxycholic acid
scispacy 1
약물 [BACKGROUND] scispacy 1
약물 [OBJECTIVES] scispacy 1
약물 [RESULTS] A scispacy 1
약물 neurotoxin scispacy 1
약물 [CONCLUSIONS] Cosmetic facial injectables scispacy 1
기타 patients scispacy 1
기타 Patient scispacy 1
기타 neurotoxin, scispacy 1

MeSH Terms

Adult; Cosmetic Techniques; Cosmetics; Deoxycholic Acid; Humans; Neurotoxins; Rejuvenation; Retrospective Studies; Surgery, Plastic

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문